(Q33829121)

29 July 2017

1 reference

title

Governance of the concentration of plasma LDL: a reevaluation of the LDL receptor paradigm (English)

1 reference

29 July 2017

1 reference

1

Sniderman AD

1 reference

29 July 2017

3

Cianflone K

1 reference

29 July 2017

Zhang XJ

2

1 reference

29 July 2017

language of work or name

1 reference

1 February 2000

1 reference

29 July 2017

1 reference

29 July 2017

volume

148

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

215-229

1 reference

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Defective lipoprotein receptors and atherosclerosis. Lessons from an animal counterpart of familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

A receptor-mediated pathway for cholesterol homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Characterization of hepatic low density lipoprotein binding and cholesterol metabolism in normal and homozygous familial hypercholesterolemic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

In vivo regulation of human mononuclear leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase. Decreased enzyme catalytic efficiency in familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

The molecular basis of abetalipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

An inhibitor of the microsomal triglyceride transfer protein inhibits apoB secretion from HepG2 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Modulation of 3-hydroxy-3-methylglutaryl-CoA reductase and of acyl-CoA-cholesterol acyltransferase by the transfer of non-esterified cholesterol to rat liver microsomal vesicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

On the mechanism for the regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, of cholesterol 7alpha-hydroxylase and of acyl-coenzyme A:cholesterol acyltransferase by free cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in obesity: a stable isotope study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Direct correlation between cholesterol synthesis and hepatic secretion of apolipoprotein B-100 in normolipidemic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Simvastatin decreases the hepatic secretion of very‐low‐density lipoprotein apolipoprotein B‐100 in heterozygous familial hypercholesterolaemia: pathophysiological and therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Inhibition of cholesterogenesis decreases hepatic secretion of apoB-100 in normolipidemic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Effect of cell cholesterol content on apolipoprotein B secretion and LDL receptor activity in the human hepatoma cell line, HepG2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Regulation of apolipoprotein B secretion in hepatocytes from Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Cholesterol can stimulate secretion of apolipoprotein B by cultured human hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

ACAT inhibition decreases LDL cholesterol in rabbits fed a cholesterol-free diet. Marked changes in LDL cholesterol without changes in LDL receptor mRNA abundance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Inhibition of hepatic ACAT decreases ApoB secretion in miniature pigs fed a cholesterol-free diet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

TMP-153, a novel ACAT inhibitor, lowers plasma cholesterol through its hepatic action in golden hamsters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Relationship between activity of hepatic 3-hydroxy-3-methylglutaryl-coenzyme A reductase and secretion of very-low-density-lipoprotein cholesterol by the isolated perfused liver and in the intact rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Regulation of low density lipoprotein apoprotein B metabolism by lovastatin and cholestyramine in miniature pigs: effects on LDL composition and synthesis of LDL subfractions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Dietary fish oil plus lovastatin decreases both VLDL and LDL apo B production in miniature pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Comparative effects of HMG-CoA reductase inhibitors on apo B production in the casein-fed rabbit: atorvastatin versus lovastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Inhibition of cholesterol esterification by DuP 128 decreases hepatic apolipoprotein B secretion in vivo: effect of dietary fat and cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Effects of lovastatin therapy on very-low-density lipoprotein triglyceride metabolism in subjects with combined hyperlipidemia: evidence for reduced assembly and secretion of triglyceride-rich lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

The effect of lovastatin on very low-density lipoprotein apolipoprotein B production by the liver in familial combined hyperlipidaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Lovastatin therapy in familial dysbetalipoproteinemia: effects on kinetics of apolipoprotein B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Suppression of apolipoprotein B production during treatment of cholesteryl ester storage disease with lovastatin. Implications for regulation of apolipoprotein B synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Effect of pravastatin sodium, a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on very-low-density lipoprotein composition and kinetics in hyperlipidemia associated with experimental nephrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Lovastatin decreases de novo cholesterol synthesis and LDL Apo B-100 production rates in combined-hyperlipidemic males

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Cellular free cholesterol in Hep G2 cells is only partially available for down-regulation of low-density-lipoprotein receptor activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Regulation of low density lipoprotein receptor activity in primary cultures of human hepatocytes by serum lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Fecal steroid excretion in relation to the development of casein-induced hypercholesterolemia in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

The metabolism of very low density and intermediate density lipoproteins in patients with familial hypercholesterolaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Kinetic bases of the primary hyperlipidaemias: studies of apolipoprotein B turnover in genetically defined subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Cholestyramine promotes receptor-mediated low-density-lipoprotein catabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Effects of simvastatin on apoB metabolism and LDL subfraction distribution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Expanded-dose simvastatin is effective in homozygous familial hypercholesterolaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Effects of atorvastatin on the intracellular stability and secretion of apolipoprotein B in HepG2 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Dietary carbohydrate decreases 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and cholesterol synthesis in rat liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Phytosterolaemia, xanthomatosis and premature atherosclerotic arterial disease: a case with high plant sterol absorption, impaired sterol elimination and low cholesterol synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Competitive inhibition of bile acid synthesis by endogenous cholestanol and sitosterol in sitosterolemia with xanthomatosis. Effect on cholesterol 7 alpha-hydroxylase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Cholesteryl ester storage disease: hepatopathology and effects of therapy with lovastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Treatment of cholesteryl ester storage disease with combined cholestyramine and lovastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Lovastatin therapy for cholesterol ester storage disease in two sisters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Serum cholesterol response to changes in the diet: III. Differences among individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Plasma apoprotein and lipoprotein lipid levels in vegetarians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

The effects of low cholesterol, high polyunsaturated fat, and low fat diets on plasma lipid and lipoprotein cholesterol levels in normal and hypercholesterolemic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Divergent responses of the liver to increased delivery of glucose or fatty acids: implications for the pathogenesis of type IV hyperlipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Stimulation of hepatic cholesterol biosynthesis by oleic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Low density lipoprotein metabolism in familial combined hyperlipidemia. Mechanism of the multiple lipoprotein phenotypic expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Familial combined hyperlipidaemia: Use of stable isotopes to demonstrate overproduction of very low‐density lipoprotein apolipoprotein B by the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Fatty acids regulate hepatic low density lipoprotein receptor activity through redistribution of intracellular cholesterol pools

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Role of cholesterol ester mass in regulation of secretion of ApoB100 lipoprotein particles by hamster hepatocytes and effects of statins on that relationship

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Relationships of plasma and hepatic variables with rates of plasma low-density lipoprotein apolipoprotein B metabolism in baboons fed low- and high-fat diets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Significance of low density lipoprotein production in the regulations of plasma cholesterol level in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Metabolic basis of primary hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Hypo- and hyperresponse of serum cholesterol level and low density lipoprotein production and degradation to dietary cholesterol in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Lipoprotein heterogeneity and apolipoprotein B metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Impaired response of fibroblasts from patients with hyperapobetalipoproteinemia to acylation-stimulating protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Plasma acylation stimulating protein (ASP) as a predictor of impaired cellular biological response to ASP in patients with hyperapoB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Bile acid metabolism in hereditary forms of hypertriglyceridemia: evidence for an increased synthesis rate in monogenic familial hypertriglyceridemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

Metabolic modes of action of the statins in the hyperlipoproteinemias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

A familial combined hyperlipidemic kindred with impaired apolipoprotein B catabolism. Kinetics of apolipoprotein B during placebo and pravastatin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

ApoB metabolism in familial hypercholesterolemia. Inconsistencies with the LDL receptor paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Unexpected failure of bile acid malabsorption to stimulate cholesterol synthesis in sitosterolemia with xanthomatosis. Comparison with lovastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900282-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0021-9150(99)00282-8

1 reference

29 July 2017

1 reference